Company intelligence / Profile preview
NUAgo Therapeutics
Nottingham, Nottinghamshire, United Kingdomnuago.com ↗
- Ownership
- Private
- Employees
- ~5
- Development stage
- Other
01
Overview
NUAgo Therapeutics is a UK-based biotechnology company specializing in the development of regenerative medicines for nerve repair. Spun out from the University of Nottingham, the company focuses on small molecule therapeutics designed to stimulate the regrowth of damaged nerves by targeting the Nerve Up-regulation and Activation (NUA) pathway. Their primary focus is on treating peripheral nerve injuries, which currently have limited therapeutic options beyond surgery. NUAgo's approach aims to restore function and improve quality of life for patients suffering from traumatic nerve damage and potentially spinal cord injuries.
- Therapeutic areas
- Neurology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
University of Nottingham
Beyond the preview
Go deeper on NUAgo Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NUAgo Therapeutics.